Federal Jury Convicts Michigan Doctor of Distributing More Than 2 Million Stimulant Pills Through Done's ADHD Telehealth Platform

A federal jury has convicted a Michigan doctor of using a telehealth ADHD platform to prescribe stimulants at a scale that prosecutors measured in the millions of pills. The verdict is the latest in a long-running federal prosecution of Done Global, the digital health company behind the Done ADHD service, and it puts a spotlight on how controlled substances were prescribed through the platform.

What the jury found

On October 2, 2026, a federal jury in the Western District of Michigan convicted Jonathan Decker, 46, of Rockford, Michigan, of one count of conspiracy to distribute controlled substances and six counts of distribution of controlled substances. The verdict followed a trial, so the jury found the government proved those charges beyond a reasonable doubt. A conviction of this kind is a settled finding of guilt on the counts at issue, distinct from the sentencing that comes later.

According to the Justice Department, Decker was paid more than $1 million for writing the prescriptions at the center of the case, which covered more than 2 million pills of Adderall and other stimulants.

How the prescriptions were written

Prosecutors said Decker issued prescriptions for methamphetamine and amphetamines to patients without examining them. The problem the government described was not telehealth itself, but prescribing a Schedule II controlled substance with no meaningful clinical evaluation of the person receiving it.

The Justice Department pointed to specific patients. In one example, prosecutors said Decker prescribed methamphetamine to a patient who had an active substance use disorder. In another, he prescribed Adderall to a patient with diagnosed schizophrenia even after the patient's mother warned that stimulants worsened her psychotic symptoms. Stimulants are the first-line medication class for attention deficit hyperactivity disorder, but they carry known risks for people with certain psychiatric conditions and histories of substance use, which is part of why a clinical assessment matters before they are prescribed.

Done Global, the platform behind the prescriptions

Done Global, Inc. operated the Done ADHD service, a subscription telehealth platform that connected patients to clinicians and arranged prescriptions for ADHD medication. In its sentencing announcement for the company's leaders, the Justice Department said the operation used an auto-refill platform feature after an initial diagnosis to minimize follow-up appointments, a design that reduced the clinical review a patient received over time.

The company's founder and chief executive, Ruthia He, and its clinical president, David Brody, were sentenced in the Northern District of California on July 7, 2026. He received 72 months in prison and a $1 million fine, and Brody received 24 months and a $1 million fine, in a case the Justice Department described as a $90 million scheme to distribute more than 37 million pills of Adderall. The department said Medicare, Medicaid, and commercial insurers paid in excess of roughly $12.3 million as a result of the fraud.

Where Decker fits in the broader case

Decker is the 11th person convicted in the prosecution, which the Justice Department describes as a $100 million drug distribution and health care fraud scheme tied to Done. The case has moved through company officers, employees, and medical providers rather than resting on a single defendant. The Drug Enforcement Administration, IRS Criminal Investigation, the Department of Health and Human Services Office of Inspector General, and Homeland Security Investigations investigated.

Why this matters for telehealth ADHD care

Stimulants for ADHD are Schedule II controlled substances, the tier with the strictest prescribing controls. The Done cases turn on prescriptions written without an adequate evaluation and on a business model that, prosecutors said, rewarded volume. They are enforcement actions against specific conduct, not a ruling that prescribing ADHD medication by telehealth is unlawful.

The backdrop is a set of federal and state rules that are still settling. The Drug Enforcement Administration's telemedicine special registration framework for prescribing controlled substances remotely has been working through the rulemaking process, and states have been revising their own telehealth rules for Schedule II drugs, including a 2026 New Jersey law that added an adult stimulant pathway while keeping an in-person examination as the default. The common thread is that a controlled substance prescription is expected to rest on a real clinical judgment about the individual patient.

What is still pending

Decker has been convicted but not yet sentenced. The Justice Department said the charges carry a statutory maximum of up to 140 years in prison, a ceiling across the counts rather than a likely term. Actual federal sentences are set under the sentencing guidelines and the judge's discretion and are typically far below statutory maximums. No sentencing date has been announced.

This is general information, not medical or legal advice. Patients who take ADHD medication prescribed through a legitimate telehealth clinician do not need to act on this verdict, and anyone with questions about their own prescription should raise them with their prescriber or pharmacist. For the facts of the case, the Justice Department's announcements and the court record are the primary sources.